Home > Insider Trading > Filing (0001225208-24-006325)

Filing Details

Accession Number:: 0001225208-24-006325
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-05-23 16:12:12
Reporting Period:: 2024-05-22

Accepted Time:: 2024-05-23 16:12:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885725	Boston Scientific Corp	BSX	Surgical & Medical Instruments & Apparatus (3841)	042695240

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1595612	J. Daniel Brennan	300 Boston Scientific Way Marlborough MA 01752-1234	Evp And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-05-22	16,863	$24.55	288,405	No	4	M	Direct
Common Stock	Acquisiton	2024-05-22	16,863	$17.26	305,268	No	4	M	Direct
Common Stock	Acquisiton	2024-05-22	15,642	$27.09	320,910	No	4	M	Direct
Common Stock	Acquisiton	2024-05-22	15,086	$16.31	335,996	No	4	M	Direct
Common Stock	Disposition	2024-05-22	64,454	$75.91	271,542	No	4	S	Direct
Common Stock	Disposition	2024-05-23	47,621	$75.11	223,921	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2024-05-22	15,642	$0.00	15,642	$27.09
Common Stock	Stock Option (Right to Buy)	Disposition	2024-05-22	16,863	$0.00	16,863	$17.26
Common Stock	Stock Option (Right to Buy)	Disposition	2024-05-22	15,086	$0.00	15,086	$16.31
Common Stock	Stock Option (Right to Buy)	Disposition	2024-05-22	16,863	$0.00	16,863	$24.55

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
46,927	2028-02-15	No	4	M	Direct
16,865	2026-02-22	No	4	M	Direct
15,087	2025-02-23	No	4	M	Direct
55,600	2027-02-28	No	4	M	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 21, 2024.
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $75.512 to $76.22, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $74.86 to $75.48, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.